• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

银屑病与主要不良心血管事件:观察性研究的系统评价和荟萃分析。

Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies.

机构信息

Division of Cardiovascular Medicine, University of California, DavisSacramento, CA 95816, USA.

出版信息

J Am Heart Assoc. 2013 Apr 4;2(2):e000062. doi: 10.1161/JAHA.113.000062.

DOI:10.1161/JAHA.113.000062
PMID:23557749
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3647278/
Abstract

BACKGROUND

Psoriasis is a chronic inflammatory disease that may be associated with increased risk of cardiovascular events, including cardiovascular mortality, myocardial infarction, and stroke.

METHODS AND RESULTS

We searched the MEDLINE, EMBASE, and Cochrane Central Register databases for relevant studies in English between January 1, 1980, and January 1, 2012. Extraction was by 3 independent reviewers. Summary incidence, risk ratios (RRs), and confidence intervals (CIs) were calculated using fixed-effects and random-effects modeling. Meta-regression was also performed to identify sources of between-study variation. Nine studies were included, representing a total of 201 239 patients with mild and 17 415 patients with severe psoriasis. The level of covariate adjustment varied among studies, leading to the possibility of residual confounding. Using the available adjusted effect sizes, mild psoriasis remained associated with a significantly increased risk of myocardial infarction (RR, 1.29; 95% CI, 1.02 to 1.63) and stroke (RR, 1.12; 95% CI, 1.08 to 1.16). Severe psoriasis was associated with a significantly increased risk of cardiovascular mortality (RR, 1.39; 95% CI, 1.11 to 1.74), myocardial infarction (RR, 1.70; 95% CI, 1.32 to 2.18), and stroke (RR, 1.56 95% CI, 1.32 to 1.84). Based on these risk ratios and the background population event rates, psoriasis is associated with an estimated excess of 11 500 (95% CI, 1169 to 24 407) major adverse cardiovascular events each year.

CONCLUSIONS

Mild and severe psoriasis are associated with an increased risk of myocardial infarction and stroke. Severe psoriasis is also associated with an increased risk of cardiovascular mortality. Future studies should include more complete covariate adjustment and characterization of psoriasis severity.

摘要

背景

银屑病是一种慢性炎症性疾病,可能与心血管事件风险增加有关,包括心血管死亡率、心肌梗死和中风。

方法和结果

我们在 MEDLINE、EMBASE 和 Cochrane 中央注册数据库中检索了 1980 年 1 月 1 日至 2012 年 1 月 1 日期间的英文相关研究。提取由 3 位独立评审员进行。使用固定效应和随机效应模型计算汇总发病率、风险比 (RR) 和置信区间 (CI)。还进行了荟萃回归以确定研究间差异的来源。纳入了 9 项研究,共代表 201 239 例轻度银屑病患者和 17 415 例重度银屑病患者。研究之间的协变量调整水平不同,可能存在残余混杂。使用可用的调整后效应大小,轻度银屑病与心肌梗死 (RR,1.29;95%CI,1.02 至 1.63) 和中风 (RR,1.12;95%CI,1.08 至 1.16) 的风险显著增加相关。重度银屑病与心血管死亡率 (RR,1.39;95%CI,1.11 至 1.74)、心肌梗死 (RR,1.70;95%CI,1.32 至 2.18) 和中风 (RR,1.56;95%CI,1.32 至 1.84) 的风险显著增加相关。基于这些风险比和背景人群的事件发生率,估计每年银屑病会导致超过 11 500 例 (95%CI,1169 至 24 407 例) 主要不良心血管事件。

结论

轻度和重度银屑病与心肌梗死和中风的风险增加有关。重度银屑病也与心血管死亡率的风险增加有关。未来的研究应包括更完整的协变量调整和更准确的银屑病严重程度描述。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0936/3647278/99dbeab3ffdb/jah3-2-e000062-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0936/3647278/116dff3611ee/jah3-2-e000062-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0936/3647278/9be22c71cbfc/jah3-2-e000062-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0936/3647278/99dbeab3ffdb/jah3-2-e000062-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0936/3647278/116dff3611ee/jah3-2-e000062-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0936/3647278/9be22c71cbfc/jah3-2-e000062-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0936/3647278/99dbeab3ffdb/jah3-2-e000062-g3.jpg

相似文献

1
Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies.银屑病与主要不良心血管事件:观察性研究的系统评价和荟萃分析。
J Am Heart Assoc. 2013 Apr 4;2(2):e000062. doi: 10.1161/JAHA.113.000062.
2
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
5
Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review.银屑病和银屑病关节炎的心血管发病率和死亡率:系统文献回顾。
J Eur Acad Dermatol Venereol. 2013 Aug;27 Suppl 3:12-29. doi: 10.1111/jdv.12163.
6
Home versus in-centre haemodialysis for people with kidney failure.居家透析与中心透析治疗肾衰竭患者的效果比较。
Cochrane Database Syst Rev. 2024 Apr 8;4(4):CD009535. doi: 10.1002/14651858.CD009535.pub3.
7
Smoking cessation for secondary prevention of cardiovascular disease.戒烟对心血管疾病二级预防的作用。
Cochrane Database Syst Rev. 2022 Aug 8;8(8):CD014936. doi: 10.1002/14651858.CD014936.pub2.
8
Patient education in the management of coronary heart disease.冠心病管理中的患者教育
Cochrane Database Syst Rev. 2017 Jun 28;6(6):CD008895. doi: 10.1002/14651858.CD008895.pub3.
9
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.减少或无麸质饮食对心血管疾病一级预防的影响。
Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD013556. doi: 10.1002/14651858.CD013556.pub2.
10
Hormone therapy for preventing cardiovascular disease in post-menopausal women.激素疗法预防绝经后女性心血管疾病
Cochrane Database Syst Rev. 2015 Mar 10;2015(3):CD002229. doi: 10.1002/14651858.CD002229.pub4.

引用本文的文献

1
A Common Genetic Background for Psoriasis and Cardiovascular Diseases: A Narrative Review.银屑病与心血管疾病的共同遗传背景:一篇综述
Health Sci Rep. 2025 Aug 13;8(8):e71128. doi: 10.1002/hsr2.71128. eCollection 2025 Aug.
2
Cardiovascular and Kidney Outcomes After Systemic Treatment for Plaque Psoriasis: A Systematic Review and Network Meta-analysis.斑块状银屑病系统治疗后的心血管和肾脏结局:一项系统评价与网状Meta分析
Dermatol Ther (Heidelb). 2025 Jul 5. doi: 10.1007/s13555-025-01472-5.
3
Repurposing FDA approved drugs for psoriasis indications through integrated molecular docking, one-SVM algorithm, and molecular dynamics simulation approaches.

本文引用的文献

1
Association between tumor necrosis factor inhibitor therapy and myocardial infarction risk in patients with psoriasis.银屑病患者中肿瘤坏死因子抑制剂治疗与心肌梗死风险之间的关联。
Arch Dermatol. 2012 Nov;148(11):1244-50. doi: 10.1001/archdermatol.2012.2502.
2
Abnormal lipoprotein particles and cholesterol efflux capacity in patients with psoriasis.银屑病患者的异常脂蛋白颗粒和胆固醇流出能力。
Atherosclerosis. 2012 Sep;224(1):218-21. doi: 10.1016/j.atherosclerosis.2012.06.068. Epub 2012 Jul 21.
3
The impact of psoriasis on 10-year Framingham risk.
通过整合分子对接、单支持向量机算法和分子动力学模拟方法,将美国食品药品监督管理局(FDA)批准的药物用于银屑病适应症的重新利用。
Sci Rep. 2025 Jul 1;15(1):21211. doi: 10.1038/s41598-025-01448-7.
4
Psoriasis.银屑病
Nat Rev Dis Primers. 2025 Jun 26;11(1):45. doi: 10.1038/s41572-025-00630-5.
5
Pathophysiology of Myopenia in rheumatoid arthritis.类风湿关节炎中肌肉减少症的病理生理学
Bone Res. 2025 Jun 16;13(1):64. doi: 10.1038/s41413-025-00438-9.
6
Practical Recommendations on Cardiovascular Risk Evaluation in Patients With Psoriasis and Psoriatic Arthritis for Dermatologists, Rheumatologists, and Primary Care Physicians by the Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network.银屑病和银屑病关节炎临床多中心推进网络为皮肤科医生、风湿病学家和初级保健医生提供的关于银屑病和银屑病关节炎患者心血管风险评估的实用建议
J Psoriasis Psoriatic Arthritis. 2025 May 28:24755303251337020. doi: 10.1177/24755303251337020.
7
Ultra-Processed Food Consumption and the Risk of Psoriasis: A Large Prospective Cohort Study.超加工食品消费与银屑病风险:一项大型前瞻性队列研究。
Nutrients. 2025 Apr 27;17(9):1473. doi: 10.3390/nu17091473.
8
Cardiovascular and metabolic outcomes associated with moderate-to-severe atopic dermatitis: A systematic review and meta-analysis.中度至重度特应性皮炎相关的心血管和代谢结局:一项系统评价和荟萃分析。
World Allergy Organ J. 2025 Feb 28;18(3):101035. doi: 10.1016/j.waojou.2025.101035. eCollection 2025 Mar.
9
Diet and Psoriasis-Related Information on Instagram: A Quality and Content Analysis of Posts Under Popular Psoriasis Hashtags.Instagram上与饮食和银屑病相关的信息:对热门银屑病主题标签下帖子的质量与内容分析
J Hum Nutr Diet. 2025 Apr;38(2):e70034. doi: 10.1111/jhn.70034.
10
Improving Cardiovascular Outcomes in the Psoriasis Cohort. Psoriasis and Cardiovascular Disease-Clinician Knowledge, Practice and Perceptions.改善银屑病患者群体的心血管结局。银屑病与心血管疾病——临床医生的知识、实践与认知。
Australas J Dermatol. 2025 Jun;66(4):e187-e196. doi: 10.1111/ajd.14436. Epub 2025 Feb 22.
银屑病对弗明汉10年风险的影响。
J Am Acad Dermatol. 2012 Oct;67(4):796-8. doi: 10.1016/j.jaad.2012.05.016. Epub 2012 Jun 26.
4
Coronary artery disease in patients with psoriasis referred for coronary angiography.银屑病患者行冠状动脉造影术的冠状动脉疾病。
Am J Cardiol. 2012 Apr 1;109(7):976-80. doi: 10.1016/j.amjcard.2011.11.025. Epub 2012 Jan 3.
5
Heart disease and stroke statistics--2012 update: a report from the American Heart Association.《2012年心脏病和中风统计数据更新:美国心脏协会报告》
Circulation. 2012 Jan 3;125(1):e2-e220. doi: 10.1161/CIR.0b013e31823ac046. Epub 2011 Dec 15.
6
A review of health outcomes in patients with psoriasis.银屑病患者健康结局的综述。
Dermatol Clin. 2012 Jan;30(1):61-72, viii. doi: 10.1016/j.det.2011.08.012. Epub 2011 Oct 19.
7
Are patients with psoriasis being screened for cardiovascular risk factors? A study of screening practices and awareness among primary care physicians and cardiologists.银屑病患者是否接受心血管危险因素筛查?初级保健医生和心脏病专家筛查实践和认知的研究。
J Am Acad Dermatol. 2012 Sep;67(3):357-62. doi: 10.1016/j.jaad.2011.09.006. Epub 2011 Nov 12.
8
Underdiagnosis and undertreatment of cardiovascular risk factors in patients with moderate to severe psoriasis.中重度银屑病患者心血管风险因素的漏诊和治疗不足。
J Am Acad Dermatol. 2012 Jul;67(1):76-85. doi: 10.1016/j.jaad.2011.06.035. Epub 2011 Oct 22.
9
Association between biologic therapies for chronic plaque psoriasis and cardiovascular events: a meta-analysis of randomized controlled trials.生物制剂治疗慢性斑块状银屑病与心血管事件的相关性:随机对照试验的荟萃分析。
JAMA. 2011 Aug 24;306(8):864-71. doi: 10.1001/jama.2011.1211.
10
Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease.甲氨蝶呤的使用与心血管疾病风险的系统评价和荟萃分析。
Am J Cardiol. 2011 Nov 1;108(9):1362-70. doi: 10.1016/j.amjcard.2011.06.054. Epub 2011 Aug 17.